New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - cyproterone acetate 2mg;  ;  ; ethinylestradiol 0.035mg;   - film coated tablet - active: cyproterone acetate 2mg     ethinylestradiol 0.035mg   excipient: hypromellose lactose monohydrate magnesium stearate povidone propylene glycol purified talc   quinoline yellow starch titanium dioxide colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propylene glycol purified talc   starch titanium dioxide - androgen-dependent diseases in women are an indication for treatment with ginet. these diseases may include: acne (where local treatment or oral antibiotics alone have not been successful), especially pronounced forms of acne that may be accompanied by inflammation or formation of nodes (acne nodulocystica, acne papulopustulosa), seborrhea, mild forms of hirsutism and/or androgenic alopecia. oral contraception in women requiring treatment for these androgen-dependent diseases is an indication for treatment with ginet. however ginet is not recommended in women solely for contraception. it should not be used in combination with other hormonal contraceptives. ginet is indicated for the relief of symptoms of polycystic ovary syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - cyproterone acetate 2mg; ethinylestradiol 0.035mg - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose - · the treatment of signs of androgenisation in women, such as severe acne (involving inflammation or nodularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cyproterone acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate - inoperable prostatic carcinoma. to suppress flare with initial luteinising hormone releasing hormone (lhrh) analogue therapy; in long-term palliative treatment where lhrh analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with lhrh analogues or who have had orchidectomy.

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - cyproterone acetate - tablet - cyproterone acetate 50 mg - sex hormones and modulators of the genital system

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - cyproterone acetate; ethinylestradiol - coated tablet - 2 mg/35 microgram(s) - cyproterone and estrogen

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - cyproterone acetate ; ethinylestradiol - coated tablets - 2/35 mg/mcg - cyproterone and estrogen - antiandrogens and estrogens - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, dianette should only be used after topical therapy or systemic antibiotic treatments have failed.

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - cyproterone acetate; ethinylestradiol - coated tablet - 2 mg/35 microgram(s) - cyproterone and estrogen

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (germany) - estradiol valerate; cyproterone acetate - oral tablet - 2mg ; 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - cyproterone acetate - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - cyproterone acetate - oral tablet - 50mg